CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Cardiol Therapeutics Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026
$1.10+0.00 (0.00%)
Close on Oct 19, 2026
Cardiol Therapeutics statistics
Financials through Dec 31, 2025, price-based ratios appear once a share price is available, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Cardiol Therapeutics | Industry median |
|---|---|---|
| Market Cap | C$157.36M | C$123.83M |
| Enterprise Value | C$135.95M | C$93.80M |
Income (trailing twelve months)
| Measure | Cardiol Therapeutics | Industry median |
|---|---|---|
| Operating Income | -C$34.32M | -C$16.55M |
| EBITDA | -C$34.32M | -C$16.37M |
| EPS (Diluted) | -0.39 CAD | -0.19 CAD |
Returns
| Measure | Cardiol Therapeutics | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | -191.0% | -17.2% |
Balance sheet
| Measure | Cardiol Therapeutics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | C$21.42M | C$27.83M |
| Net Cash (Debt) | C$21.42M | C$27.83M |
| Net Cash Per Share | 0.21 CAD | 0.25 CAD |
| Working Capital | C$17.85M | C$25.22M |
Financial position
| Measure | Cardiol Therapeutics | Industry median |
|---|---|---|
| Current Ratio | 4.16 | 2.65 |
| Quick Ratio | 3.80 | 1.40 |
Cash flow (trailing twelve months)
| Measure | Cardiol Therapeutics | Industry median |
|---|---|---|
| Operating Cash Flow | -C$23.85M | -C$8.69M |
| Capital Expenditures | -C$24.48K | -C$510.54K |
| Free Cash Flow | -C$23.88M | -C$11.52M |
| FCF Per Share | -0.24 CAD | -0.07 CAD |
Dividends and yields
| Measure | Cardiol Therapeutics | Industry median |
|---|---|---|
| FCF Yield | -15.2% | -8.07% |
| Buyback Yield | -10.2% | -9.44% |
| Shareholder Yield | -10.2% | -9.44% |
Shares
| Measure | Cardiol Therapeutics | Industry median |
|---|---|---|
| Shares Outstanding | 100,257,000 | 74,643,400 |
| Shares Change (YoY) | 21.5% | 18.0% |
| Float | 78,946,900 | 74,292,200 |
| Shares Held by Insiders | 21.3% | 0.00% |
| Shares Held by Institutions | 29.4% | 9.14% |
Scores
| Measure | Cardiol Therapeutics | Industry median |
|---|---|---|
| Altman Z-Score | -0.07 | -0.68 |
Calculated by StockData from Cardiol Therapeutics's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.